Adaptive, Amgen collaborate on development of COVID-19 treatment
April 02, 2020 at 19:58 PM EDT
The drug will rely on Seattle-based Adaptive’s immune medicine platform to identify antibodies that neutralize the virus using samples taken from patients who have already recovered from COVID-19.
